Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency

Daclizumab is a humanized monoclonal antibody that blocks CD25, the high affinity alpha subunit of the interleukin-2 receptor. Daclizumab therapy targets T regulatory cell and activated effector T cell prolife...

https://ift.tt/2NQFWNz